Oncogenes and tumor-suppressor genes in mesothelioma--a synopsis.

Por Lechner, J F, Tesfaigzi, J, Gerwin, B I
Publicado em 1997

The role of transforming growth factor alpha production and ErbB-2 overexpression in induction of tumorigenicity of lung epithelial cells.

Por Hamburger, A. W., Fernandes, A., Murakami, M., Gerwin, B. I.
Publicado em 1998

Abrogation of Fv-1b restriction with murine leukemia viruses inactivated by heat or by gamma irradiation.

Por Bassin, R H, Duran-Troise, G, Gerwin, B I, Rein, A
Publicado em 1978

Donation of N- or B-tropic phenotype to NB-tropic murine leukemia virus during mixed infections.

Por Kashmiri, S V, Rein, A, Bassin, R H, Gerwin, B I, Gisselbrecht, S
Publicado em 1977

Molecular properties of a gag- pol- env+ murine leukemia virus from cultured AKR lymphoma cells.

Por Rein, A, Lowy, D R, Gerwin, B I, Ruscetti, S K, Bassin, R H
Publicado em 1982

Murine leukemia virus mutant with a frameshift in the reverse transcriptase coding region: implications for pol gene structure.

Por Levin, J G, Hu, S C, Rein, A, Messer, L I, Gerwin, B I
Publicado em 1984

A replication-defective variant of Moloney murine leukemia virus. I. Biological characterization.

Por Rein, A L, Gerwin, B I, Bassin, R H, Schwarm, L, Schidlovsky, G
Publicado em 1978

High levels of MDM2 are not correlated with the presence of wild-type p53 in human malignant mesothelioma cell lines.

Por Ungar, S., Van de Meeren, A., Tammilehto, L., Linnainmaa, K., Mattson, K., Gerwin, B. I.
Publicado em 1996

Cell density governs the ability of human bronchial epithelial cells to recognize serum and transforming growth factor beta-1 as squamous differentiation-inducing agents.

Por Ke, Y., Gerwin, B. I., Ruskie, S. E., Pfeifer, A. M., Harris, C. C., Lechner, J. F.
Publicado em 1990

Macromolecular requirements for abrogation of Fv-1 restriction by murine leukemia viruses.

Por Bassin, R H, Gerwin, B I, Levin, J G, Duran-Troise, G, Benjers, B M, Rein, A
Publicado em 1980

Oncogenes and tumor-suppressor genes.

Por Lehman, T A, Reddel, R, Peiifer, A M, Spillare, E, Kaighn, M E, Weston, A, Gerwin, B I, Harris, C C
Publicado em 1991

Functional organization of the murine leukemia virus reverse transcriptase: characterization of a bacterially expressed AKR DNA polymerase deficient in RNase H activity.

Por Levin, J G, Crouch, R J, Post, K, Hu, S C, McKelvin, D, Zweig, M, Court, D L, Gerwin, B I
Publicado em 1988

Mutant of B-tropic murine leukemia virus synthesizing an altered polymerase molecule.

Por Gerwin, B I, Rein, A, Levin, J G, Bassin, R H, Benjers, B M, Kashmiri, S V, Hopkins, D, O'Neill, B J
Publicado em 1979

Mutations and altered expression of p16INK4 in human cancer.

Por Okamoto, A, Demetrick, D J, Spillare, E A, Hagiwara, K, Hussain, S P, Bennett, W P, Forrester, K, Gerwin, B, Serrano, M, Beach, D H
Publicado em 1994

Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transforming growth factor beta 1.

Por Gerwin, B I, Spillare, E, Forrester, K, Lehman, T A, Kispert, J, Welsh, J A, Pfeifer, A M, Lechner, J F, Baker, S J, Vogelstein, B
Publicado em 1992

Establishment of a human in vitro mesothelial cell model system for investigating mechanisms of asbestos-induced mesothelioma.

Por Ke, Y., Reddel, R. R., Gerwin, B. I., Reddel, H. K., Somers, A. N., McMenamin, M. G., LaVeck, M. A., Stahel, R. A., Lechner, J. F., Harris, C. C.
Publicado em 1989